These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 26940993)

  • 21. Cardiac transplantation in children with Noonan syndrome.
    McCallen LM; Ameduri RK; Denfield SW; Dodd DA; Everitt MD; Johnson JN; Lee TM; Lin AE; Lohr JL; May LJ; Pierpont ME; Stevenson DA; Chatfield KC
    Pediatr Transplant; 2019 Sep; 23(6):e13535. PubMed ID: 31259454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Delineation of LZTR1 mutation-positive patients with Noonan syndrome and identification of LZTR1 binding to RAF1-PPP1CB complexes.
    Umeki I; Niihori T; Abe T; Kanno SI; Okamoto N; Mizuno S; Kurosawa K; Nagasaki K; Yoshida M; Ohashi H; Inoue SI; Matsubara Y; Fujiwara I; Kure S; Aoki Y
    Hum Genet; 2019 Jan; 138(1):21-35. PubMed ID: 30368668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PHENOTYPIC CONSEQUENCES AND THE MALIGNANCY RISK IN FAMILIAL NOONAN SYNDROME DUE TO A RARE P.S427G RAF1 MUTATION.
    Pelc M; Ciara E; Jezela-Stanek A; Krajewska-Walasek M
    Genet Couns; 2016; 27(3):325-333. PubMed ID: 30204961
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PTPN11, SOS1, KRAS, and RAF1 gene analysis, and genotype-phenotype correlation in Korean patients with Noonan syndrome.
    Ko JM; Kim JM; Kim GH; Yoo HW
    J Hum Genet; 2008; 53(11-12):999-1006. PubMed ID: 19020799
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Gene mutation and clinical phenotype analysis of patients with Noonan syndrome and hypertrophic cardiomyopathy].
    Liu XH; Ding WW; Han L; Liu XR; Xiao YY; Yang J; Mo Y
    Zhonghua Er Ke Za Zhi; 2017 Oct; 55(10):780-784. PubMed ID: 29050118
    [No Abstract]   [Full Text] [Related]  

  • 26. Cardiovascular disease in Noonan syndrome.
    Pierpont ME; Digilio MC
    Curr Opin Pediatr; 2018 Oct; 30(5):601-608. PubMed ID: 30024444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Co-occurrence of hypertrophic cardiomyopathy and myeloproliferative disorder in a neonate with Noonan syndrome carrying Thr73Ile mutation in PTPN11.
    Yagasaki H; Nakane T; Hasebe Y; Watanabe A; Kise H; Toda T; Koizumi K; Hoshiai M; Sugita K
    Am J Med Genet A; 2015 Dec; 167A(12):3144-7. PubMed ID: 26286251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Signalosome-Regulated Serum Response Factor Phosphorylation Determining Myocyte Growth in Width Versus Length as a Therapeutic Target for Heart Failure.
    Li J; Tan Y; Passariello CL; Martinez EC; Kritzer MD; Li X; Li X; Li Y; Yu Q; Ohgi K; Thakur H; MacArthur JW; Ivey JR; Woo YJ; Emter CA; Dodge-Kafka K; Rosenfeld MG; Kapiloff MS
    Circulation; 2020 Dec; 142(22):2138-2154. PubMed ID: 32933333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of ERK1/2 signaling in congenital valve malformations in Noonan syndrome.
    Krenz M; Gulick J; Osinska HE; Colbert MC; Molkentin JD; Robbins J
    Proc Natl Acad Sci U S A; 2008 Dec; 105(48):18930-5. PubMed ID: 19017799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RAF1 deficiency causes a lethal syndrome that underscores RTK signaling during embryogenesis.
    Wong S; Tan YX; Loh AYT; Tan KY; Lee H; Aziz Z; Nelson SF; Özkan E; Kayserili H; Escande-Beillard N; Reversade B
    EMBO Mol Med; 2023 May; 15(5):e17078. PubMed ID: 37066513
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Noonan syndrome associated with both a new Jnk-activating familial SOS1 and a de novo RAF1 mutations.
    Longoni M; Moncini S; Cisternino M; Morella IM; Ferraiuolo S; Russo S; Mannarino S; Brazzelli V; Coi P; Zippel R; Venturin M; Riva P
    Am J Med Genet A; 2010 Sep; 152A(9):2176-84. PubMed ID: 20683980
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activating MRAS mutations cause Noonan syndrome associated with hypertrophic cardiomyopathy.
    Motta M; Sagi-Dain L; Krumbach OHF; Hahn A; Peleg A; German A; Lissewski C; Coppola S; Pantaleoni F; Kocherscheid L; Altmüller F; Schanze D; Logeswaran T; Chahrokh-Zadeh S; Munzig A; Nakhaei-Rad S; Cavé H; Ahmadian MR; Tartaglia M; Zenker M
    Hum Mol Genet; 2020 Jul; 29(11):1772-1783. PubMed ID: 31108500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RAS signaling pathway mutations and hypertrophic cardiomyopathy: getting into and out of the thick of it.
    Gelb BD; Tartaglia M
    J Clin Invest; 2011 Mar; 121(3):844-7. PubMed ID: 21339640
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nonreentrant atrial tachycardia occurs independently of hypertrophic cardiomyopathy in RASopathy patients.
    Levin MD; Saitta SC; Gripp KW; Wenger TL; Ganesh J; Kalish JM; Epstein MR; Smith R; Czosek RJ; Ware SM; Goldenberg P; Myers A; Chatfield KC; Gillespie MJ; Zackai EH; Lin AE
    Am J Med Genet A; 2018 Aug; 176(8):1711-1722. PubMed ID: 30055033
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor spectrum in children with Noonan syndrome and SOS1 or RAF1 mutations.
    Denayer E; Devriendt K; de Ravel T; Van Buggenhout G; Smeets E; Francois I; Sznajer Y; Craen M; Leventopoulos G; Mutesa L; Vandecasseye W; Massa G; Kayserili H; Sciot R; Fryns JP; Legius E
    Genes Chromosomes Cancer; 2010 Mar; 49(3):242-52. PubMed ID: 19953625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expanding the clinical phenotype of RASopathies in 38 Turkish patients, including the rare LZTR1, RAF1, RIT1 variants, and large deletion in NF1.
    Uludağ Alkaya D; Lissewski C; Yeşil G; Zenker M; Tüysüz B
    Am J Med Genet A; 2021 Dec; 185(12):3623-3633. PubMed ID: 34184824
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A boy with Burkitt lymphoma associated with Noonan syndrome due to a mutation in RAF1.
    Cianci P; Tono V; Sala A; Locatelli L; Carta C; Rizzari C; Biondi A; Selicorni A
    Am J Med Genet A; 2013 Jun; 161A(6):1401-4. PubMed ID: 23613113
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and molecular characterization of children with Noonan syndrome and other RASopathies in Argentina.
    Chinton J; Huckstadt V; Moresco A; Gravina LP; Obregon MG
    Arch Argent Pediatr; 2019 Oct; 117(5):330-337. PubMed ID: 31560489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Restrictive and hypertrophic cardiomyopathies in Noonan syndrome: the overlap syndromes.
    Wilmshurst PT; Katritsis D
    Heart; 1996 Jan; 75(1):94-7. PubMed ID: 8624883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RAF1 variants causing biventricular hypertrophic cardiomyopathy in two preterm infants: further phenotypic delineation and review of literature.
    Thompson D; Patrick-Esteve J; Surcouf JW; Rivera D; Castellanos B; Desai P; Lilje C; Lacassie Y; Marble M; Zambrano R
    Clin Dysmorphol; 2017 Oct; 26(4):195-199. PubMed ID: 28777121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.